Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Scion Asset Management, LLC

Q2 2025 · 13F-HR

Scion Asset Management, LLCholdings as filed

Filed 2025-08-14 · accession 0001879202-25-000038

$578.3M
Reported value
15
Positions
2025-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
91324P102UNHUNITEDHEALTH GROUP INC$109.2M18.9%350,000CALLSOLE
75886F107REGNREGENERON PHARMACEUTICALS$105.0M18.2%200,000CALLSOLE
550021109LULULULULEMON ATHLETICA INC$95.0M16.4%400,000CALLSOLE
30303M102METAMETA PLATFORMS INC$73.8M12.8%100,000CALLSOLE
518439104ELLAUDER ESTEE COS INC$40.4M6.99%500,000CALLSOLE
47215P106JDJD.COM INC$32.6M5.64%1,000,000CALLSOLE
01609W102BABAALIBABA GROUP HLDG LTD$28.4M4.90%250,000CALLSOLE
N07059210ASMLASML HOLDING N V$20.0M3.46%25,000CALLSOLE
918204108VFCV F CORP$17.6M3.05%1,500,000CALLSOLE
518439104ELLAUDER ESTEE COS INC$12.1M2.10%150,000CommonSOLE
550021109LULULULULEMON ATHLETICA INC$11.9M2.05%50,000CommonSOLE
116794108BRKRBRUKER CORP$10.3M1.78%250,000CommonSOLE
75886F107REGNREGENERON PHARMACEUTICALS$7.9M1.36%15,000CommonSOLE
58733R102MELIMERCADOLIBRE INC$7.8M1.36%3,000CommonSOLE
91324P102UNHUNITEDHEALTH GROUP INC$6.2M1.08%20,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.